The 2016 presidential election cycle brought a flurry of support for cannabis policies across the US. This year, five states will ask voters to decide on a variety of cannabis programs.

While cannabis regulation in the US can get bogged down by the development of federal bills — such as the recent Marijuana Opportunity, Reinvestment and Expungement Act (MORE Act) — the story is different at the state level, and several cannabis programs have launched thanks to voter support.

While the winner of the presidential election will draw significant attention from the marijuana sector, investors will also have to keep an eye on the results of these state elections as they will likely dictate the game plans of some of the publicly traded cannabis operators in the US.

Despite roadblocks such as a lack of federal policy on the cannabis industry, 33 states have legalized medical cannabis and 11 have done the same for recreational use. The expansion of these cannabis laws shows the support legalization has with all kinds of voters — in fact, the latest data from polling agency Gallup shows that 66 percent of Americans support cannabis legalization.

Matt Carr, chief trends strategist at the Oxford Club, said that while cannabis policy changes may come as a direct result of who wins the presidency, the state votes are a positive sign all around.

“(The votes) give us a nice tailwind over the next few months, and I think give us a tailwind into 2021 because this is again showing that these markets are expanding,” he said.

The expert explained that the path to legalization for these states has been spurred by interest in tax revenue, which might then become critical for budget plans moving forward.

Read on to learn which states will have cannabis measures on their ballots on November 3.


In 2016, Arizona came close to legalizing cannabis for recreational use, and a new measure will try again in 2020. The state already has an established medical market program.

The legalization vote joined the ballot after the Smart and Safe Arizona campaign secured the necessary signatures, over 250,000, a report from Cannabis Wire indicates.

Prominent cannabis companies like Harvest Health & Recreation (CSE:HARV,OTCQX:HRVSF), Curaleaf Holdings (CSE:CURA,OTCQX:CURLF) and Cresco Labs (CSE:CL,OTCQX:CRLBF) have all thrown financial support behind the legalization measure.

Even though the vote came very close last time around, a win for the “no” vote side secured with 51.3 percent of voters.

Arizona Governor Doug Ducey has strongly campaigned against the legalization measure — his main argument against recreational legalization focuses on claims like increased road dangers and potential use by minors, particularly teens, according to a report from Marijuana Moment.


The voters in Mississippi have a tricky vote ahead of them as they will be casting a decision on Initiative 65 and Alternative 65A, two amendments designed for a medical cannabis program.

The distinction between the two measurements, according to Ballotpedia News, comes down to limitations on cannabis use.

The first piece of legislation would allow the use of medical cannabis for patients facing 22 specified conditions. Under this legislation, patients would be allowed to carry up to 2.5 ounces of cannabis, but smoking wouldn’t be permitted in public places.

Meanwhile, 65A wouldn’t specify the medical conditions needed to secure medical cannabis. In addition to that, 65A would make it so terminally ill patients can smoke cannabis.

Initiative 65 would introduce a 7 percent tax for cannabis sales, determined by the state’s sales tax rate.

There’s been dispute at the local level regarding the value and intention behind having similar measures for cannabis policy up for vote. Advocates told Marijuana Moment that Alternative 65A is a “deliberately vague” piece of policy proposed by the state’s Senate.


Voters in Montana can relate to those in Mississippi, as they too will see two cannabis measures on their ballots on election day.

Local campaign group New Approach Montana obtained the needed signatures to bring Initiative 190, a recreational cannabis legalization bill, in front of voters.

The second piece of legislation, Constitutional Initiative 118, builds on Initiative 190 and would make it so only those 21 and older can buy and possess legal cannabis in the state.

According to The Hill, the cannabis legalization policy would also introduce a 20 percent tax on all non-medical cannabis products sold in the state.

US Election 2020 and Cannabis

Investing in cannabis? Read what experts have to say about cannabis and the US Election!

New Jersey

New Jersey is one of the most watched markets by cannabis experts because a legalization effort there could affect neighboring state New York.

While Governor Phil Murphy has tried to move the legalization issue along through an in-house policy, after various arduous delays recreational legalization efforts will now be left in the hands of voters.

The policy, Public Question No. 1, will ask voters to legalize recreational sales in the state, a measure that is already getting strong support.

The measure would introduce a state sales tax for recreational cannabis products and would make it so the authority overseeing medical sales would also regulate the new adult-use products.

South Dakota

South Dakota is on the brink of doing something no other state has done so far in the legalization path of cannabis: It may legalize both medical and recreational cannabis at the same time this election cycle.

Measure 26 will ask voters to decide on the creation of a medical cannabis program for the state, while Amendment A would legalize adult-use cannabis sales.

According to Marijuana Business Daily, it’s hard to predict the outcome in South Dakota as there have been no independent polls on support for the cannabis cause. Local advocates have said perspectives on the issue have changed, but the medical measure may have a stronger chance to make it.

Don’t forget to follow us @INN_Cannabis for real-time updates!

Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

Editorial Disclosure: The Investing News Network does not guarantee the accuracy or thoroughness of the information reported in the interviews it conducts. The opinions expressed in these interviews do not reflect the opinions of the Investing News Network and do not constitute investment advice. All readers are encouraged to perform their own due diligence.

US Election 2020 and Cannabis

Investing in cannabis? Read what experts have to say about cannabis and the US Election!


Harvest Health & Recreation Inc. (” Harvest ” or the ” Company “)  ( CSE: HARV ), a vertically integrated cannabis company and multi-state operator in the U.S., is pleased to announce that, further to its news releases dated October 21, 2020 and October 22, 2020  the Company has completed its previously announced bought deal public offering of 20,354,080 units (the ” Units “), including 2,654,880 Units issued pursuant to the Underwriters’ (as defined herein) over-allotment option which was exercised in full by notice to the Company, at a price of $2.26 per Unit (the ” Offering Price “), for aggregate gross proceeds of $46,000,220.80 (the ” Offering “) (All figures are in Canadian dollars unless otherwise stated).

Keep reading... Show less

Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff

Credit Acceptance Corporation (NASDAQ:CACC)
Class Period:
November 1, 2019 – August 28, 2020
Deadline: December 1, 2020
For more info:

Keep reading... Show less

Campaign includes a $50,000 donation to Wounded Warriors by Spectrum Therapeutics and an internal fundraiser to raise additional contributions through November

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED) (NYSE:CGC), through its medical division Spectrum Therapeutics, is honoured to announce a donation campaign for the month of November in support of Wounded Warriors Canada (“WWC”) and its mental health services for Veterans and First Responders.

Keep reading... Show less

Company expands LLR portfolio to provide more options for consumers’ changing preferences

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or “the Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today the launch of a 1.0 g Liquid Live Resin (LLR) vape cartridge in its Cresco brand portfolio. Illinois and California are the first markets to carry the Company’s newest LLR offering. Cresco Labs’ LLR is unique and differentiated from other live resin products in market today because the Company uses an extraction process that flash-freezes whole flower at peak freshness, preserving premium flavor, cannabinoids and quality.

Keep reading... Show less

4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) (” 4Front ” or the ” Company “) announced today that it has entered into definitive purchase and sale agreements with an affiliate of Innovative Industrial Properties, Inc., ( IIPR ) providing for the sale and leaseback of 4Front’s cultivation and production facilities in Tumwater, WA and Georgetown, MA (the ” Transaction “).

The all cash sale price of US$30 million will be used by the Company to pay down the outstanding senior secured debt obligation to affiliates of Gotham Green Partners, and for other general corporate purposes. The Transaction is subject to various closing conditions, including standard property/title inspections and appraisals and is scheduled to close in early December.

Keep reading... Show less